M Mattheus
Overview
Explore the profile of M Mattheus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
80
Followers
0
Related Specialty
Related Specialty
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Macha S, Rose P, Mattheus M, Cinca R, Pinnetti S, Broedl U, et al.
Diabetes Obes Metab
. 2013 Jul;
16(2):118-23.
PMID: 23859534
Aims: This open-label, parallel-group study investigated the effect of various degrees of hepatic impairment on the pharmacokinetics, safety and tolerability of the sodium glucose cotransporter 2 inhibitor empagliflozin. Methods: Thirty-six...
2.
Macha S, Mattheus M, Halabi A, Pinnetti S, Woerle H, Broedl U
Diabetes Obes Metab
. 2013 Jul;
16(3):215-22.
PMID: 23859488
Aims: Empagliflozin is a selective sodium glucose cotransporter 2 (SGLT2) inhibitor that inhibits renal glucose reabsorption and is being investigated for the treatment of type 2 diabetes mellitus (T2DM). Methods:...
3.
Macha S, Rose P, Mattheus M, Pinnetti S, Woerle H
Diabetes Obes Metab
. 2012 Oct;
15(4):316-23.
PMID: 23094794
Aim: To investigate potential drug-drug interactions between empagliflozin and warfarin. Methods: Healthy subjects (n = 18) received empagliflozin 25 mg qd for 5 days (treatment A), followed by empagliflozin 25 ...